Page last updated: 2024-08-23

zidovudine and Lymphoma, Primary Effusion

zidovudine has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hislop, AD; Nicol, SM; Sabbah, S; Stürzl, M; Williamson, SJ	1

Other Studies

1 other study(ies) available for zidovudine and Lymphoma, Primary Effusion

Article	Year
Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function. PLoS pathogens, 2016, Volume: 12, Issue:11 Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Interferon Regulatory Factors; Lymphoma, Primary Effusion; Polymerase Chain Reaction; Tumor Escape; Viral Proteins; Zidovudine	2016

Article

Year

Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.

PLoS pathogens, 2016, Volume: 12, Issue:11

Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Interferon Regulatory Factors; Lymphoma, Primary Effusion; Polymerase Chain Reaction; Tumor Escape; Viral Proteins; Zidovudine

2016